Mechanisms of cardiac fibrosis in hypertension

Javier Díez1

  • 1Centre for Applied Medical Research, Department of Cardiology and Cardiovascular Surgery, University Clinic, University of Navarra, School of Medicine, Pamplona, Spain. jadimar@unav.es

Insights

Hypertensive heart disease causes myocardial fibrosis by disrupting collagen balance, leading to excessive collagen accumulation. This fibrosis contributes to heart failure in patients with hypertension.

Area of Science:

  • Cardiology
  • Pathology
  • Biochemistry

Background:

  • Hypertension leads to left ventricular hypertrophy and cardiac tissue remodeling.
  • Collagen synthesis and degradation balance is disrupted in hypertensive heart disease.
  • Excessive collagen accumulation, or myocardial fibrosis, is a key pathological change.

Purpose of the Study:

  • To review the mechanisms underlying myocardial fibrosis in hypertensive heart disease.
  • To highlight the clinical relevance of fibrosis in cardiac complications.

Main Methods:

  • Review of existing literature on hypertensive myocardial fibrosis.
  • Focus on the pathological processes and contributing factors.

Main Results:

  • Myocardial fibrosis results from disrupted collagen homeostasis (types I and III).
  • Pathological processes involve mechanical, neurohormonal, and cytokine pathways.
  • Fibrosis contributes to heart failure and other cardiac issues.

Conclusions:

  • Understanding the mechanisms of hypertensive myocardial fibrosis is crucial.
  • Fibrosis is a significant contributor to adverse cardiac events in hypertensive patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...